Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani.

导出 OA

翻译打印收藏纠错

第一作者： M Shamim Hasan,Zahid

第一单位： Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA.

作者： M Shamim Hasan,Zahid ^[1] ; Monica M,Johnson ^[1] ; Robert J,Tokarski ^[2] ; Abhay R,Satoskar ^[3] ; James R,Fuchs ^[2] ; Eric M,Bachelder ^[1] ; Kristy M,Ainslie ^[4]

作者单位： Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. ^[1] Division of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, The Ohio State University, Columbus, OH, 43210, USA. ^[2] Department of Pathology, Medical Center, The Ohio State University, Columbus, OH, 43210, USA. ^[3] Division of Pharmacoengineering and Molecular Pharmaceutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, 27599, USA. Electronic address: ainsliek@email.unc.edu. ^[4]

关键词 AR-12 Combinatorial therapy DNER-4 Host-directed therapy Resazurin assay Visceral leishmaniasis